RxDoctor Payments Data

Nick Gunasayan

Foot & Ankle Surgery · San Luis Obispo, CANPI 1417903337

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Biotissue Holdings Inc. at 42.6% of the total. Among foot & ankle surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$68,511in general payments, 2019–2025

Across 274 payments — averaging $250.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$29K
  • Fusion Orthopedics USA, LLC$13K
  • Treace Medical Concepts, Inc.$12K
  • Smith+Nephew$3K
  • Cornerstone Medical Associates, Inc.$2K
  • Paragon 28, Inc.$2K
  • plus $6K from 28 others

What the payments were for

  • Consulting fees$23,80035%
  • Speaking & faculty fees$4,5007%
  • Travel & lodging$26,73639%
  • Food & beverage$13,47520%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,511 in reported general payments places this provider in the 95th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California

Medicare billing

Part B allowed, 2024
$155,477
Medicare patients
515
Services billed
1,571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl23$187
Cephalexin24$176
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$82
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$79
Gabapentin11$45

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in San Luis Obispo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →